{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:31:06Z","timestamp":1790109066519,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":52,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG052350"],"award-info":[{"award-number":["P01AG052350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50AG016573"],"award-info":[{"award-number":["P50AG016573"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG060049"],"award-info":[{"award-number":["R01AG060049"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG064228"],"award-info":[{"award-number":["R01AG064228"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARG-17-532905"],"award-info":[{"award-number":["AARG-17-532905"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["DFD-170763"],"award-info":[{"award-number":["DFD-170763"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cerebral Circulation - Cognition and Behavior"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.cccb.2022.100131","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T02:17:39Z","timestamp":1646101059000},"page":"100131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Platelet-derived growth factor-BB and white matter hyperintensity burden in APOE4 carriers"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-8951","authenticated-orcid":false,"given":"Arunima","family":"Kapoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A","family":"Nation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cccb.2022.100131_bib0001","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cccb.2022.100131_bib0002","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cccb.2022.100131_bib0003","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.cccb.2022.100131_bib0004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/nan.12529","article-title":"Invited review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease","volume":"45","author":"Tzioras","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.cccb.2022.100131_bib0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","article-title":"APOE attenuates unresolvable inflammation by complex formation with activated C1q","volume":"25","author":"Yin","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cccb.2022.100131_bib0006","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1194\/jlr.R075408","article-title":"The role of APOE on lipid homeostasis and inflammation in normal brains","volume":"58","author":"Rebeck","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cccb.2022.100131_bib0007","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/JMN:23:3:205","article-title":"A dual role for apolipoprotein E in neuroinflammation: anti- and pro-inflammatory activity","volume":"23","author":"Guo","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.cccb.2022.100131_bib0008","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cccb.2022.100131_bib0009","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Standards for reporting vascular changes on neuroimaging (STRIVE v1), neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cccb.2022.100131_bib0010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cccb.2022.100131_bib0011","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood\u2013brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cccb.2022.100131_bib0012","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/jcbfm.2013.76","article-title":"The APOE \u03b54\/\u03b54 Genotype potentiates vascular fibrin(Ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients","volume":"33","author":"Hultman","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cccb.2022.100131_bib0013","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-510X(02)00288-5","article-title":"Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease","volume":"203\u2013204","author":"Salloway","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cccb.2022.100131_bib0014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cccb.2022.100131_bib0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-021-00073-z","article-title":"APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer's mice via cyclophilin A independently of amyloid-\u03b2","volume":"1","author":"Montagne","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.cccb.2022.100131_bib0016","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.cccb.2022.100131_bib0017","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13195-019-0534-8","article-title":"CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology","volume":"11","author":"Miners","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cccb.2022.100131_bib0018","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cccb.2022.100131_bib0019","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jalz.2015.05.002","article-title":"Magnetic resonance imaging in Alzheimer's disease neuroimaging initiative 2","volume":"11","author":"Jack","year":"2015","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.cccb.2022.100131_bib0020","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.cccb.2022.100131_bib0021","first-page":"239","article-title":"Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR","volume":"21","author":"Schwarz","year":"2009","journal-title":"Inf. Process. Med. Imaging"},{"key":"10.1016\/j.cccb.2022.100131_bib0022","author":"DeCarli"},{"key":"10.1016\/j.cccb.2022.100131_bib0023","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jalz.2010.03.013","article-title":"Alzheimer's disease neuroimaging initiative biomarkers as quantitative phenotypes: genetics core aims, progress, and plans","volume":"6","author":"Saykin","year":"2010","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.cccb.2022.100131_bib0024","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cccb.2022.100131_bib0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0271678X17690761","article-title":"Differing associations between A\u03b2 accumulation, hypoperfusion, blood\u2013brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease","volume":"38","author":"Miners","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cccb.2022.100131_bib0026","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1177\/0271678X18769515","article-title":"PDGFR-\u03b2 restores blood-brain barrier functions in a mouse model of focal cerebral ischemia","volume":"39","author":"Shen","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cccb.2022.100131_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134594","article-title":"Oligodendrocytes upregulate blood-brain barrier function through mechanisms other than the PDGF-BB\/PDGFR\u03b1 pathway in the barrier-tightening effect of oligodendrocyte progenitor cells","volume":"715","author":"Kimura","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cccb.2022.100131_bib0028","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.STR.28.3.564","article-title":"A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans","volume":"28","author":"Krupinski","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.cccb.2022.100131_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.711784","article-title":"Increased levels of circulating angiogenic cells and signaling proteins in older adults with cerebral small vessel disease","volume":"13","author":"Kapoor","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cccb.2022.100131_bib0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2217\/bmm-2020-0350","article-title":"CD34+ cells and endothelial progenitor cell subpopulations are associated with cerebral small vessel disease burden","volume":"15","author":"Huang","year":"2021","journal-title":"Biomark. Med."},{"key":"10.1016\/j.cccb.2022.100131_bib0031","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00702-009-0226-9","article-title":"Evidence of angiogenic vessels in Alzheimer's disease","volume":"116","author":"Desai","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.cccb.2022.100131_bib0032","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1038\/s41467-021-23337-z","article-title":"Non-productive angiogenesis disassembles A\u00df plaque-associated blood vessels","volume":"12","author":"Alvarez-Vergara","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cccb.2022.100131_bib0033","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(03)12521-4","article-title":"Alzheimer's disease and angiogenesis","volume":"361","author":"Vagnucci","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cccb.2022.100131_bib0034","series-title":"Identifying the Mechanism of A\u03b242 Inhibition of PDGF-BB Signalling","author":"Saffi","year":"2013"},{"key":"10.1016\/j.cccb.2022.100131_bib0035","doi-asserted-by":"crossref","first-page":"19276","DOI":"10.1523\/JNEUROSCI.3487-13.2013","article-title":"Neuronal clearance of amyloid- by endocytic receptor LRP1","volume":"33","author":"Kanekiyo","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cccb.2022.100131_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.05.025","article-title":"LRP1 mediates bidirectional transcytosis of amyloid-\u03b2 across the blood-brain barrier","volume":"32","author":"Pflanzner","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cccb.2022.100131_bib0037","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2015.09.025","article-title":"Shedding of soluble platelet-derived growth factor receptor-\u03b2 from human brain pericytes","volume":"607","author":"Sagare","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cccb.2022.100131_bib0038","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.cccb.2022.100131_bib0039","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mam.2017.11.007","article-title":"The PDGF\/PDGFR pathway as a drug target","volume":"62","author":"Papadopoulos","year":"2018","journal-title":"Mol. Asp. Med."}],"container-title":["Cerebral Circulation - Cognition and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666245022000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666245022000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:27:19Z","timestamp":1762979239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666245022000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":39,"alternative-id":["S2666245022000964"],"URL":"https:\/\/doi.org\/10.1016\/j.cccb.2022.100131","relation":{},"ISSN":["2666-2450"],"issn-type":[{"value":"2666-2450","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-derived growth factor-BB and white matter hyperintensity burden in APOE4 carriers","name":"articletitle","label":"Article Title"},{"value":"Cerebral Circulation - Cognition and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cccb.2022.100131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100131"}}